414 related articles for article (PubMed ID: 28717351)
1. Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.
Thelin EP; Zeiler FA; Ercole A; Mondello S; Büki A; Bellander BM; Helmy A; Menon DK; Nelson DW
Front Neurol; 2017; 8():300. PubMed ID: 28717351
[TBL] [Abstract][Full Text] [Related]
2. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
3. Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study.
Menditto VG; Moretti M; Babini L; Mattioli A; Giuliani AR; Fratini M; Pallua FY; Andreoli E; Nitti C; Contucci S; Gabrielli A; Rocchi MBL; Pomponio G
Clin Chem Lab Med; 2024 Jun; 62(7):1376-1382. PubMed ID: 38206121
[TBL] [Abstract][Full Text] [Related]
4. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond.
Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S
J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670
[TBL] [Abstract][Full Text] [Related]
5. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study.
Åkerlund CAI; Holst A; Bhattacharyay S; Stocchetti N; Steyerberg E; Smielewski P; Menon DK; Ercole A; Nelson DW;
Lancet Neurol; 2024 Jan; 23(1):71-80. PubMed ID: 37977157
[TBL] [Abstract][Full Text] [Related]
6. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.
Amoo M; Henry J; O'Halloran PJ; Brennan P; Husien MB; Campbell M; Caird J; Javadpour M; Curley GF
Neurosurg Rev; 2022 Apr; 45(2):1171-1193. PubMed ID: 34709508
[TBL] [Abstract][Full Text] [Related]
7. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
[TBL] [Abstract][Full Text] [Related]
8. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions.
Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B
Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363
[TBL] [Abstract][Full Text] [Related]
10. Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data.
Robba C; Graziano F; Picetti E; Åkerlund C; Addis A; Pastore G; Sivero M; Rebora P; Galimberti S; Stocchetti N; Maas A; Menon DK; Citerio G;
Intensive Care Med; 2024 Mar; 50(3):371-384. PubMed ID: 38376517
[TBL] [Abstract][Full Text] [Related]
11. Serum biomarkers identify critically ill traumatic brain injury patients for MRI.
Richter S; Winzeck S; Czeiter E; Amrein K; Kornaropoulos EN; Verheyden J; Sugar G; Yang Z; Wang K; Maas AIR; Steyerberg E; Büki A; Newcombe VFJ; Menon DK;
Crit Care; 2022 Nov; 26(1):369. PubMed ID: 36447266
[TBL] [Abstract][Full Text] [Related]
12. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
13. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
14. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
[TBL] [Abstract][Full Text] [Related]
15. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
[TBL] [Abstract][Full Text] [Related]
16. Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis.
Mondello S; Sorinola A; Czeiter E; Vámos Z; Amrein K; Synnot A; Donoghue E; Sándor J; Wang KKW; Diaz-Arrastia R; Steyerberg EW; Menon DK; Maas AIR; Buki A
J Neurotrauma; 2021 Apr; 38(8):1086-1106. PubMed ID: 29020853
[TBL] [Abstract][Full Text] [Related]
17. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
Park DW; Park SH; Hwang SK
Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
[TBL] [Abstract][Full Text] [Related]
18. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
19. Association of Biomarkers of Neuronal Injury and Inflammation With Insomnia Trajectories After Traumatic Brain Injury: A TRACK-TBI Study.
Werner JK; Albrecht J; Capaldi VF; Jain S; Sun X; Mukherjee P; Williams SG; Collen J; Diaz-Arrastia R; Manley GT; Krystal AD; Wickwire E;
Neurology; 2024 Apr; 102(8):e209269. PubMed ID: 38547447
[TBL] [Abstract][Full Text] [Related]
20. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
